UPDATE: SVB Leerink On Humana Outperform Initiation: Firm Believes Near-Term Concerns Of Rebounding Medical & COVID Costs Are Priced In; Sees Accelerating Growth Environment With FY22 Inflection & Closing Valuation Spread With UnitedHealth Group